Loss of PBRM1 function causes a reduction in IFNγ-STAT1 signaling in both murine and human RCC cell lines; thus, PBRM1 inactivation leads to a less immunogenic TME [79]. The gene discussed is PBRM1; the disease is renal cell carcinoma.